Kathleen M Naughton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kathleen M Naughton has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Deanna M. Green
Division of Pediatric Pulmonology and Cystic Fibrosis, Johns Hopkins All Children’s Hospital, St. Petersburg, FL 33701, USA
1 shared publication - Garry R. Cutting
Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
1 shared publication - Joseph Michael Collaco
Johns Hopkins Medical Institutions Baltimore Maryland USA
1 shared publication - Kathryn E McDougal
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
1 shared publication - Lindsay B Henderson
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication - Patrick R. Sosnay
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication
Latest Publications
- Open Access
- 8 October 2010
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 140
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF.
- 8 October 2010
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 140
Open AccessMutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF.